384 related articles for article (PubMed ID: 20445837)
1. Personality disorders in ADHD Part 3: Personality disorder, social adjustment, and their relation to dimensions of adult ADHD.
Reimherr FW; Marchant BK; Williams ED; Strong RE; Halls C; Soni P
Ann Clin Psychiatry; 2010 May; 22(2):103-12. PubMed ID: 20445837
[TBL] [Abstract][Full Text] [Related]
2. Personality disorder in ADHD Part 1: Assessment of personality disorder in adult ADHD using data from a clinical trial of OROS methylphenidate.
Williams ED; Reimherr FW; Marchant BK; Strong RE; Halls C; Soni P; Gale PD; Robison RJ
Ann Clin Psychiatry; 2010 May; 22(2):84-93. PubMed ID: 20445835
[TBL] [Abstract][Full Text] [Related]
3. Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD.
Robison RJ; Reimherr FW; Gale PD; Marchant BK; Williams ED; Soni P; Halls C; Strong RE
Ann Clin Psychiatry; 2010 May; 22(2):94-102. PubMed ID: 20445836
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
5. OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study.
Marchant BK; Reimherr FW; Halls C; Williams ED; Strong RE
Ann Clin Psychiatry; 2010 Aug; 22(3):196-204. PubMed ID: 20680193
[TBL] [Abstract][Full Text] [Related]
6. Oppositional defiant disorder in adults with ADHD.
Reimherr FW; Marchant BK; Olsen JL; Wender PH; Robison RJ
J Atten Disord; 2013 Feb; 17(2):102-13. PubMed ID: 22100691
[TBL] [Abstract][Full Text] [Related]
7. Relationships of neuroticism and extraversion with axis I and II comorbidity among patients with DSM-IV major depressive disorder.
Jylhä P; Melartin T; Isometsä E
J Affect Disord; 2009 Apr; 114(1-3):110-21. PubMed ID: 18687471
[TBL] [Abstract][Full Text] [Related]
8. Inattention and hyperactivity dimensions of ADHD are associated with different personality profiles.
Salgado CA; Bau CH; Grevet EH; Fischer AG; Victor MM; Kalil KL; Sousa NO; Garcia CR; Belmonte-de-Abreu P
Psychopathology; 2009; 42(2):108-12. PubMed ID: 19225245
[TBL] [Abstract][Full Text] [Related]
9. Severity of childhood attention-deficit hyperactivity disorder--a risk factor for personality disorders in adult life?
Matthies S; van Elst LT; Feige B; Fischer D; Scheel C; Krogmann E; Perlov E; Ebert D; Philipsen A
J Pers Disord; 2011 Feb; 25(1):101-14. PubMed ID: 21309626
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.
Levin FR; Evans SM; Brooks DJ; Garawi F
Drug Alcohol Depend; 2007 Feb; 87(1):20-9. PubMed ID: 16930863
[TBL] [Abstract][Full Text] [Related]
11. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.
Golubchik P; Sever J; Zalsman G; Weizman A
Int Clin Psychopharmacol; 2008 Jul; 23(4):228-31. PubMed ID: 18446088
[TBL] [Abstract][Full Text] [Related]
12. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
13. Frequency of comorbid personality disorders in bipolar and unipolar affective disorders.
Brieger P; Ehrt U; Marneros A
Compr Psychiatry; 2003; 44(1):28-34. PubMed ID: 12524633
[TBL] [Abstract][Full Text] [Related]
14. Personality Disorder in Adult Attention-Deficit/Hyperactivity Disorder: Attrition and Change During Long-term Treatment.
Gift TE; Reimherr FW; Marchant BK; Steans TA; Wender PH
J Nerv Ment Dis; 2016 May; 204(5):355-63. PubMed ID: 27082828
[TBL] [Abstract][Full Text] [Related]
15. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV
J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder.
Gau SS; Ni HC; Shang CY; Soong WT; Wu YY; Lin LY; Chiu YN
Aust N Z J Psychiatry; 2010 Feb; 44(2):135-43. PubMed ID: 20113302
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
[TBL] [Abstract][Full Text] [Related]
18. Axis I and II comorbidity in adults with ADHD.
Miller TW; Nigg JT; Faraone SV
J Abnorm Psychol; 2007 Aug; 116(3):519-28. PubMed ID: 17696708
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
[TBL] [Abstract][Full Text] [Related]
20. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
